Treatment of climacteric symptoms in survivors of gynaecological cancer

Maturitas

Volumn 82, Issue 3, 2015, Pages 296-298

  Biglia, Nicoletta ^a   Bounous, Valentina Elisabetta ^a   Sgro, Luca Giuseppe ^a   D'Alonzo, Marta ^a   Gallo, Martina ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cervical cancer; Endometrial cancer; Gynaecological survivors; Hormone replacement therapy (HRT); Ovarian cancer

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ALTERNATIVE MEDICINE; CANCER SURVIVOR; ENDOMETRIUM CANCER; FEMALE; FEMALE GENITAL TRACT CANCER; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE; OVARY CANCER; QUALITY OF LIFE; RECURRENCE RISK; REVIEW; UTERINE CERVIX CANCER; UTERUS SARCOMA; ADVERSE EFFECTS; CHEMICALLY INDUCED; CONTRAINDICATIONS; DYSPAREUNIA; GENITAL NEOPLASMS, FEMALE; HOT FLASHES; SLEEP DISORDERS, INTRINSIC; SURVIVOR; TUMOR RECURRENCE;

DYSPAREUNIA; FEMALE; GENITAL NEOPLASMS, FEMALE; HORMONE REPLACEMENT THERAPY; HOT FLASHES; HUMANS; MENOPAUSE; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; SLEEP DISORDERS, INTRINSIC; SURVIVORS;

EID: 84945475706     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2015.07.006     Document Type: Review

References (20)

1. The North American Menopause Society (NAMS) The 2012 hormone therapy position statement of the North American menopause society menopause Menopause 19 2012 1 257
2. F. Guidozzi Estrogen therapy in gynecological cancer survivors Climacteric 16 2013 611 617
3. J.E. Manson, R.T. Chlebowski, M.L. Stefanick, A.K. Aragaki, J.E. Rossouw, R.L. Prentice, and et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials JAMA 310 13 2013 1353 1368
4. W.T. Creasman, D. Henderson, W. Hinshaw, and D.L. Clarke-Pearson Estrogen replacement therapy in the patient treated for endometrial cancer Obstet. Gynecol. 67 1986 326 330
5. R.B. Lee, T.W. Burke, and R.C. Park Estrogen replacement therapy following treatment for stage I endometrial carcinoma Gynecol. Oncol. 36 1990 189 191
6. J.A. Chapman, P.J. DiSaia, and K. Osann Estrogen replacement in surgical stage I and II endometrial cancer survivors Am. J. Obstet. Gynecol. 175 1996 1195 1200
7. K.A. Suriano, M. McHale, C.E. McLaren, K.T. Li, A. Re, and P.J. DiSaia Estrogen replacement therapy in endometrial cancer patients: a matched control study Obstet. Gynecol. 97 2001 555 560
8. A. Ayhan, C. Taskiran, S. Simsek, and A. Sever Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors? Int. J. Gynecol. Cancer 16 2006 805 808
9. R.R. Barakat, B.N. Bundy, N.M. Spirtos, J. Bell, and R.S. Mannel Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology group study J. Clin. Oncol. 24 2006 587 592
10. G.L. Anderson, H.L. Judd, A.M. Kaunitz, D.H. Barad, S.A. Beresford, M. Pettinger, and et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the women's health initiative randomized trial JAMA 290 13 2003 1739 1748
11. S.-H. Shim, S.J. Lee, and S.-N. Kim Effects of hormone replacement therapy on the rateof recurrence in endometrial cancer survivors: a meta-analysis Eur. J. Cancer 50 2014 1628 1637
12. M. Levgur Estrogen and combined hormone therapy for women after genital malignancies J. Reprod. Med. 49 2004 837 848
13. W.J. Koh, B.E. Greer, N.R. Abu-Rustum, S.M. Apte, S.M. Campos, J. Chan, and et al. Uterine neoplasms, version 1.2014 J. Natl. Compr. Cancer Netw. 12 2 2014 248 280
14. E. Ploch Hormonal replacement therapy in patients after cervical cancer treatment Gynecol. Oncol. 26 1987 169 177
15. Collaborative Group on Epidemiological Studies of ovarian cancer, V. Beral, H. Gaitskell, C. Hermon, K. Moser, G. Reeves, and R. Peto Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies Lancet 385 9980 2015 1835 1842
16. R.A. Eeles, S. Tan, E. Wiltshaw, I. Fryatt, R.P. A'Hern, J.H. Shepherd, and et al. Hormo replacement therapy and survival after surgery for ovarian cancer BMJ 302 1991 259 262
17. F. Guidozzi, and A. Da Ponte Estrogen replacement therapy for ovarian carcinoma survivors. A randomized controlled study Cancer 86 1999 1013 1018
18. M. Ursic-Vrscaj Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival Menopause 8 2001 1460 1465
19. C. Mascarenhas, M. Lambe, R. Bellocco, K. Bergfeldt, T. Riman, I. Persson, and et al. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian survival Int. J. Cancer 119 2006 2907 2915
20. J. Drewe, K.A. Bucher, and C. Zahner A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients SpringerPlus 4 2015 65